CORONAVIRUS DISEASE (COVID-19) Clinical Trials

175 clinical trials for CORONAVIRUS DISEASE (COVID-19) across international registries, including 54 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• A Clinical Study of Molnupiravir to Prevent Severe Illness From Coronavirus Disease 2019 (COVID-19) in People Who Are High Risk (MK-4482-023) — RECRUITING · PHASE3
• ADAPTIVE PLATFORM TRIAL OF TREATMENTS FOR RESPIRATORY INFECTIONS IN COMMUNITY SETTINGS (TREATRESP) — RECRUITING
• AN INTERVENTIONAL EFFICACY AND SAFETY, PHASE 3, DOUBLE-BLIND, 2-ARM STUDY TO INVESTIGATE ORALLY ADMINISTERED IBUZATRELVIR COMPARED WITH PLACEBO IN NON-HOSPITALIZED SYMPTOMATIC ADULT AND ADOLESCENT PARTICIPANTS WITH COVID-19 WHO ARE AT HIGH RISK OF PROGRESSING TO SEVERE ILLNESS — RECRUITING · PHASE3
• PHASE 1/2 STUDY TO EVALUATE SAFETY AND IMMUNOGENICITY OF A PROPHYLACTIC PLASMID DNA BOOSTER VACCINE AGAINST SARS-COV- -002] IN GENERALLY HEALTHY ADULTS 18 YEARS AND OLDER — RECRUITING · PHASE1
• A PHASE 2 TRIAL TO EVALUATE SAFETY AND IMMUNOGENICITY OF A NEXT-GENERATION COVID-19 VACCINE DELIVERED BY INHALED AEROSOL TO HUMANS — RECRUITING · PHASE2
• A PHASE I/III RANDOMIZED, DOUBLE-BLIND STUDY TO EVALUATE THE SAFETY AND NEUTRALIZING ACTIVITY OF AZD5156/AZD3152 FOR PRE-EXPOSURE PROPHYLAXIS OF COVID-19 IN PARTICIPANTS WITH CONDITIONS CAUSING IMMUNE IMPAIRMENT — RECRUITING · PHASE1
• PLATFORM OF RANDOMIZED ADAPTIVE CLINICAL TRIALS IN CRITICAL ILLNESS (PRACTICAL) RANDOMIZED CONTROL TRIAL — RECRUITING
• CANADIAN ADAPTIVE PLATFORM TRIAL OF TREATMENTS FOR COVID IN COMMUNITY SETTINGS (CANTREATCOVID) — RECRUITING
• A RANDOMIZED, OBSERVER-BLIND, DOSE ESCALATION, PLACEBO-CONTROLLED, PHASE 1 CLINICAL TRIAL TO STUDY THE SAFETY AND IMMUNOGENICITY OF A COVAC-1 BOOSTER DOSE IN GENERALLY HEALTHY ADULTS — RECRUITING · PHASE1
• COVID-19 VACCINE BOOSTER IN IMMUNOCOMPROMISED RHEUMATIC DISEASES (COVBIRD) — RECRUITING
• "LONG COVID-19" ON THE HUMAN BRAIN — RECRUITING
• A PHASE 1/2 CLINICAL TRIAL TO STUDY SAFETY, TOLERABILITY, AND IMMUNOGENICITY OF A COVAC-2 BOOSTER DOSE IN GENERALLY HEALTHY ADULTS — RECRUITING · PHASE1
• COVID-19 VACCINE IN IMMUNOSUPPRESSED ADULTS WITH AUTOIMMUNE DISEASES — RECRUITING
• PHASE 1, OPEN LABEL STUDY TO EVALUATE THE SAFETY AND IMMUNOGENICITY OF CHAD68 AND ADHU5 VECTOR-BASED TRIVALENT COVID-19 VACCINES DELIVERED VIA INHALED AEROSOL. — RECRUITING · PHASE1
• RANDOMIZED, DOUBLE-BLINDED, PLACEBO-CONTROLLED STUDY EVALUATING VORTIOXETINE FOR COGNITIVE DEFICITS IN PERSONS WITH POST-COVID-19 CONDITION — RECRUITING
• A PHASE 2/3, TWO-PART, OPEN-LABEL, DOSE-ESCALATION, AGE DE-ESCALATION AND RANDOMIZED, OBSERVER-BLIND, PLACEBO-CONTROLLED EXPANSION STUDY TO EVALUATE THE SAFETY, TOLERABILITY, REACTOGENICITY, AND EFFECTIVENESS OF MRNA-1273 SARS-COV-2 VACCINE IN HEALTHY CHILDREN 6 MONTHS TO LESS THAN 12 YEARS OF AGE — RECRUITING · PHASE2
• DIETARY SUPPLEMENTS TO REDUCE SYMPTOMS SEVERITY AND DURATION IN PEOPLE WITH SARS-COV-2: A RANDOMIZED, DOUBLE-BLIND, PLACEBO CONTROLLED CLINICAL TRIAL — RECRUITING
• A PHASE II RANDOMIZED, DOUBLE-BLIND, PLACEBO CONTROLLED STUDY TO EVALUATE THE ANTIVIRAL ACTIVITY SAFETY, PHARMACOKINETICS, AND EFFICACY OF RO7496998 (AT-527) IN NON-HOSPITALIZED ADULT PATIENTS WITH MILD OR MODERATE COVID-19. — RECRUITING · PHASE2
• EXTEND: NOVEL OXYGEN THERAPEUTIC NANO2 FOR MILD RESPIRATORY DISTRESS IN PHASE IB AND ARDS IN PHASE II TRIALS — RECRUITING · PHASE2
• CELLULAR IMMUNO-THERAPY FOR COVID-19 ARDS (CIRCA-19) RANDOMIZED CLINICAL TRIAL — RECRUITING
• AN OPEN-LABEL STUDY TO ASSESS THE SAFETY AND EFFECT ON CLINICAL COURSE AND KEY BIOMARKERS OF ORAL APABETALONE IN HOSPITALIZED SUBJECTS WITH COVID-19 INFECTION IN ADDITION TO STANDARD OF CARE (SOC) — RECRUITING
• EFFICACY OF CAMOSTAT MESILATE IN REDUCING SEVERITY OF COVID-19 — RECRUITING
• IMAGING NEUROINFLAMMATION IN COVID-19 AND PERSISTENT DEPRESSION WITH/WITHOUT OTHER NEUROPSYCHIATRIC SYMPTOMS — RECRUITING
• TOGETHER-TORONTO: A PHASE III RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER, TRIAL TO EVALUATE THE EFFECT OF PEGINTERFERON LAMBDA FOR THE TREATMENT OF COVID-19 — RECRUITING · PHASE3
• A RANDOMIZED, OBSERVER-BLIND, DOSE-ESCALATION PHASE I CLINICAL TRIAL OF COVAC-2 IN HEALTHY ADULTS — RECRUITING · PHASE1
• A PHASE I, FIRST-IN-HUMAN, OBSERVER-BLINDED, RANDOMIZED, PLACEBO CONTROLLED, ASCENDING DOSE STUDY TO EVALUATE THE SAFETY, TOLERABILITY, AND IMMUNOGENICITY OF PTX-COVID19-B VACCINE IN HEALTHY SERONEGATIVE ADULTS AGED 18-64 — RECRUITING · PHASE1
• COVID-19 IMMUNOLOGIC ANTIVIRAL THERAPY WITH OMALIZUMAB (CIAO TRIAL) - AN ADAPTIVE PHASE II RANDOMIZED-CONTROLLED CLINICAL TRIAL — RECRUITING · PHASE2
• LUNG STRUCTURE-FUNCTION IN SURVIVORS OF MILD AND SEVERE COVID-19 INFECTION: 129XE MRI AND CT FOR RAPID EVALUATIONS AND NEXT-WAVE HEALTHCARE PLANNING (LIVE COVID FREE) — RECRUITING
• LUNG STRUCTURE-FUNCTION IN SURVIVORS OF MILD AND SEVERE COVID19 INFECTION: 129XE MRI AND CT FOR RAPID EVALUATIONS AND NEXT-WAVE HEALTHCARE PLANNING — RECRUITING
• TREATMENT OF RESPIRATORY COMPLICATIONS ASSOCIATED WITH COVID-19 INFECTION USING WHARTON¿S JELLY (WJ)-UMBILICAL CORD (UC MESENCHYMAL STROMAL CELLS (PROTRANS®): A RANDOMIZED PHASE II CONTROLLED CLINICAL TRIAL — RECRUITING · PHASE2
• NEBULIZED FUROSEMIDE FOR PULMONARY INFLAMMATION IN INTUBATED PATIENTS WITH COVID-19 - A PHASE 2/3 STUDY — RECRUITING · PHASE2
• HOST RESPONSE MEDIATORS IN CORONAVIRUS (COVID-19) INFECTION ¿ IS THERE A PROTECTIVE EFFECT OF LOSARTAN AND OTHER ARBS ON OUTCOMES OF CORONAVIRUS INFECTION? (ARBS CORONA II) — RECRUITING
• A PHASE I-IB,DOUBLE-BLINDED, RANDOMIZED REPEATED DOSE SINGLE CENTRE, SAFETY AND IMMUNOGENICITY STUDY OF NASAL POLY-ICLC (HILTONOL®) FOR PROPHYLAXIS OF COVID-19 IN HEALTHY ADULTS — RECRUITING · PHASE1
• A RANDOMIZED, PARTIALLY-BLINDED, DOSE-RANGING PHASE 1 STUDY TO ASSESS THE SAFETY, TOLERABILITY, AND IMMUNOGENICITY OF A RECOMBINANT CORONAVIRUS-LIKE PARTICLE COVID-19 VACCINE IN ADULTS 18-55 YEARS OF AGE — RECRUITING · PHASE1
• USE OF HIGH DOSE INHALED NITRIC OXIDE IN INTUBATED PATIENTS ADMITTED WITH COVID-19 — RECRUITING
• COV-IMMUNO - A RANDOMIZED, PHASE III TRIAL OF IMMUNIZATION WITH IMM-101 VERSUS OBSERVATION FOR THE PREVENTION OF SEVERE RESPIRATORY AND COVID-19 RELATED INFECTIONS IN CANCER PATIENTS AT INCREASED RISK OF EXPOSURE — RECRUITING · PHASE3
• PHASE 3 RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTI-CENTER STUDY TO ASSESS THE EFFICACY AND SAFETY OF RUXOLITINIB IN PATIENTS WITH COVID-19 ASSOCIATED CYTOKINE STORM (RUXCOVID) — RECRUITING · PHASE3
• A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO EVALUATE THE SAFETY AND EFFICACY OF EB05 + SOC VS. PLACEBO + SOC IN ADULT HOSPITALIZED PATIENTS WITH COVID-19 — RECRUITING
• SEDATING WITH VOLATILE ANESTHETICS CRITICALLY ILL COVID-19 PATIENTS IN ICU: EFFECTS ON VENTILATORY PARAMETERS AND SURVIVAL MULTICENTRE OPEN-LABEL, PRAGMATIC, RANDOMIZED CONTROLLED TRIAL AND A PARALLEL PROSPECTIVE (NON-RANDOMIZED) COHORT STUDY — RECRUITING
• PROPRANOLOL AS AN ANXIOLYTIC TO REDUCE THE USE OF SEDATIVES FOR CRITICALLY-ILL ADULTS RECEIVING MECHANICAL VENTILATION: AN OPEN-LABEL RANDOMIZED CONTROLLED TRIAL — RECRUITING
• LESSENING ORGAN DYSFUNCTION WITH VITAMIN C ¿ COVID (LOVIT-COVID) — RECRUITING
• CELLULAR IMMUNO-THERAPY FOR COVID-19 ARDS — RECRUITING
• AN INVESTIGATION ON THE EFFECTS OF ICOSAPENT ETHYL (VASCEPA) ON INFLAMMATORY BIOMARKERS IN INDIVIDUALS WITH COVID-19 CARDIOLINK-9 — RECRUITING
• RESOLUTION: A DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED, PHASE II/III STUDY OF THE EFFICACY AND SAFETY OF LAU-7B IN THE TREATMENT OF ADULT HOSPITALIZED PATIENTS WITH COVID-19 DISEASE — RECRUITING · PHASE2
• INTERFERON LAMBDA FOR IMMEDIATE: ANTIVIRAL THERAPY AT DIAGNOSIS (ILIAD): A PHASE II RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER TRIAL TO EVALUATE THE EFFECT OF PEGINTERFERON LAMBDA FOR THE TREATMENT OF COVID-19 — RECRUITING · PHASE2
• COAGULOPATHY OF COVID-19: A PRAGMATIC RANDOMIZED CONTROLLED TRIAL OF THERAPEUTIC ANTICOAGULATION VERSUS STANDARD CARE AS A RAPID RESPONSE TO THE COVID-19 PANDEMIC (RAPID COVID COAG) — RECRUITING
• PRE-EXPOSURE PROPHYLAXIS FOR SARS-CORONAVIRUS-2: A PRAGMATIC RANDOMIZED CLINICAL TRIAL — RECRUITING
• ANTI-CORONAVIRUS THERAPIES TO PREVENT PROGRESSION OF COVID-19 (ACT), A RANDOMIZED TRIAL — RECRUITING
• ASSESSMENT OF INVESTIGATIONAL MEDICATIONS ADJUNCT TO CLINICAL STANDARD OF CARE FOR TREATMENT OF MODERATE TO SEVERE CORONAVIRUS DISEASE (COVID-19) — RECRUITING
• PROTECTING FRONTLINE HEALTH CARE WORKERS FROM COVID-19 WITH HYDROXYCHLOROQUINE PRE-EXPOSURE PROPHYLAXIS: A RANDOMIZED, PLACEBO CONTROLLED MULTI SITE TRIAL IN TORONTO, CANADA — RECRUITING

Refine this search